HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission.
Yegor Voronin and colleagues explore how monoclonal antibodies against HIV could provide a new opportunity to further reduce mother-to-child transmission of HIV and propose that new interventions should consider issues related to implementation, feasibility, and access. Please see later in the article for the Editors' Summary.
Global HIV Vaccine Enterprise, New York, New York, United States of America.
Yegor
Y
Voronin
Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland, United States of America.
Lynne M
LM
Mofenson
Duke University Medical Center, Durham, North Carolina, United States of America.
Coleen K
CK
Cunningham
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Mary G
MG
Fowler
Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda.
Pontiano
P
Kaleebu
University of Colorado School of Medicine, Denver, Colorado, United States of America.
Elizabeth J
EJ
McFarland
Elizabeth Glaser Pediatric AIDS Foundation, Los Angeles, California, United States of America.
Jeffrey T
JT
Safrit
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Barney S
BS
Graham
Global HIV Vaccine Enterprise, New York, New York, United States of America.
William
W
Snow
D000328:Adult; D000911:Antibodies, Monoclonal / Q000097:blood*; D002648:Child; D005260:Female; D006678:HIV / Q000276:immunology*; D015483:HIV Antibodies / Q000097:blood*; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission* / Q000821:virology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009035:Mothers
D000911:Antibodies, Monoclonal; D015483:HIV Antibodies